Stock ANAB ANAPTYSBIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions AnaptysBio, Inc.

Equities

ANAB

US0327241065

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
21 USD +11.29% Intraday chart for AnaptysBio, Inc. +5.69% -1.96%
Apr. 16 Leerink Partners Starts AnaptysBio With Outperform Rating, $47 Price Target MT
Apr. 11 Wells Fargo Initiates AnaptysBio With Overweight Rating, $56 Price Target MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. ANAB Stock
  4. Revisions AnaptysBio, Inc.